Medicaid Provider Alert: Provider revalidation has begun and those not completing the process risk disenrollment. Check your account now to learn when your revalidation is due. More information here.

Drugs and Therapeutics (D & T) Committee Meeting Results for June 11, 2014

Drug Name	Review Type	Committee Recommendation	Prior Approval Status � Final Determination
Vimizim	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Aerospan HFA	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Farxiga	New Drug Initial Review	Require Prior Approval	Prior Approval Required

Footer